Vancomycin IV (vancomycin)

Approved for Serious infections caused by susceptible strains of methicillin-resistant staphylococci, Treatment of endocarditis, Bone and joint infections. Inhibits bacterial cell wall synthesis by binding to D-alanyl-D-alanine terminus of cell wall precursor units, preventing polymerization. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…

Loading full data from Know Your Drugs Institute…